Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

<p><strong>Background</strong></p> Doxycycline is often used for treating COVID-19 respiratory symptoms in the community despite an absence of evidence from clinical trials to support its use. We aimed to assess the efficacy of doxycycline to treat suspected COVID-19 in the c...

書目詳細資料
Main Authors:	Butler, CC, Yu, L-M, Dorward, J, Gbinigie, O, Hayward, G, Saville, BR, Van Hecke, O, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Djukanovic, R, Gadola, S, Kirkpatrick, J, Ogburn, E, Patel, MG, de Lusignan, S, Evans, PH, Thomas, NPB, Hobbs, FDR
其他作者:	PRINCIPLE Trial Collaborative Group
格式:	Journal article
語言:	English
出版:	Elsevier 2021

相似書籍

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
由: PRINCIPLE Trial Collaborative Group, et al.
出版: (2021)

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
由: Yu, L-M, et al.
出版: (2021)

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
由: Yu, L-M, et al.
出版: (2021)

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
由: PRINCIPLE Trial Collaborative Group, et al.
出版: (2021)

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
由: Dorward, J, et al.
出版: (2022)

Inhaled budesonide for COVID-19 in people at higher risk of complications in the community: the UK National Community Randomi
由: Gbinigie, O, et al.
出版: (2023)

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
由: Hayward, G, et al.
出版: (2021)

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
由: Hayward, G, et al.
出版: (2024)

High-dose budesonide for early COVID-19 - Authors' reply
由: Hobbs, FDR, et al.
出版: (2021)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship
由: de Lusignan, S, et al.
出版: (2021)

The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: A rapid review
由: Dorward, J, et al.
出版: (2021)

Inclusion and diversity in the PRINCIPLE trial
由: Patel, MG, et al.
出版: (2021)

Suspected Doxycycline Induced Acute Interstitial Nephritis
由: Andrew Abrahamian, et al.
出版: (2023-05-01)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study.
由: de Lusignan, S, et al.
出版: (2021)

Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).
由: Raja Dhar, et al.
出版: (2023-01-01)

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
由: Butler, CC, et al.
出版: (2022)

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): preliminary analysis from the united kingdom randomised, controlled open-label, platform adaptive trial
由: Butler, C, et al.
出版: (2022)

A targeted approach to vaccine hesitancy
由: Leston, M, et al.
出版: (2023)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study
由: Simon de Lusignan, et al.
出版: (2021-10-01)

Penetration of doxycycline in aqueous humour
由: Kulshrestha O, et al.
出版: (1981-01-01)

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
由: Sarah Tonkin-Crine, et al.
出版: (2021-06-01)

Excess mortality from COVID-19 in an English sentinel network population
由: Joy, M, et al.
出版: (2020)

Doxycycline prophylaxis in malaria.
由: Gilks, C, et al.
出版: (1987)

Doxycycline induced Esophagitis
由: Banu Karakus Yilmaz, et al.
出版: (2014-02-01)

Comparison between Efficacy of Ciprofioxacin -Doxycycline with Rifampin – Doxycycline Regimens inrelapse of Brucellosis
由: Hossein Sarmadian, et al.
出版: (2014-08-01)

A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis.
由: Chaowagul, W, et al.
出版: (1999)

Transdermal Delivery System of Doxycycline-Loaded Niosomal Gels: Toward Enhancing Doxycycline Stability
由: Ahlam Zaid Alkilani, et al.
出版: (2024-07-01)

Effect of doxycycline and doxycycline with carica papaya on thrombocytopenia and leucopenia in acute dengue fever patients
由: Vivek Pambhar, et al.
出版: (2022-01-01)

Different Concentrations of Doxycycline in Swine Manure Affect the Microbiome and Degradation of Doxycycline Residue in Soil
由: Qiufan Yan, et al.
出版: (2018-12-01)

Treatment of Morgellons disease with doxycycline
由: Jeff F. Zhang, et al.
出版: (2021-12-01)

Actinic granuloma responding to doxycycline
由: George M. Jeha, BS, et al.
出版: (2020-11-01)

Doxycycline in the current clinical practice
由: Zyryanov S.K., et al.
出版: (2020-03-01)

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
由: Gbinigie, O, et al.
出版: (2023)

Evaluation of the doxycycline release from AH26 sealer-doxycycline combination: An ex vivo study
由: Kazem Ashofteh Yazdi, et al.
出版: (2011-09-01)

Doxycycline promotes proteasome fitness in the central nervous system
由: Edmund Charles Jenkins, et al.
出版: (2021-08-01)

Experiences of urine collection devices during suspected Urinary Tract Infections: qualitative study
由: Glogowska, M, et al.
出版: (2023)

Doxycycline PEP can induce doxycycline resistance in Klebsiella pneumoniae in a Galleria mellonella model of PEP
由: Chris Kenyon, et al.
出版: (2023-08-01)

Scrub typhus and the misconception of doxycycline resistance
由: Wangrangsimakul, T, et al.
出版: (2019)

Doxycycline Degradation by the Oxidative Fenton Process
由: Alexandre A. Borghi, et al.
出版: (2015-01-01)

Use of doxycycline in modern clinical practice
由: R. S. Kozlov, et al.
出版: (2014-12-01)